Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y
The average dose was about 200 mg/day, although doses ranged from 50 to 400 mg/day
In the hippocampus, BPC 157 strongly elevates Egr1 , Akt1 , Kras , Src , Foxo , Srf , Vegfr2 , Nos3, and Nos1 expression and decreases Nos2 and Nfkb expression
US$ 23.03
US$ 29.21
US$ 24.87
US$ 22.06
